4 unknown, 3 completed, 1 active not recruiting, 1 recruiting. 10 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 10 | Unknown 4, Completed 3, Active not recruiting 1, Recruiting 1, Terminated 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Iodine-131: new trials by email Literature Review of Iodine-131 trials Research Report on Iodine-131
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Conservative vs an Ablative Approach for Treatment of Hyperthyroidism in Patients With Graves' Orbitopathy Methimazole, Radioiodine or thyroidectomy - Graves' Orbitopathy | Phase 3 | Unknown | University of Pisa | 52 | 2023-03-02 | 2023-03-17 |
| Evaluation of Metformin Effect on the Fertility of Women Treated With 131I for Thyroid Cancer metformin, Radioactive iodine (I-131) - Thyroid Cancer | Phase 3 | Recruiting | Medical University of Bialystok | 160 | 2022-11-01 | 2026-10-21 |
| Radiofrequency Ablation Versus I-131 for Solitary Autonomous Thyroid Nodules Radiofrequency ablation, Radioactive iodine - Thyroid Nodule, Toxic or With Hyperthyroidism, Autonomous Thyroid Function | Phase 3 | Terminated | Rijnstate Hospital | 40 | 2021-11-17 | 2025-07-17 |
| rhTSH for Radioactive Iodine Remnant Ablation in Participants With Differentiated Thyroid Cancer (DTC) rhTSH, Radioiodine (131I) - Differentiated Thyroid Cancer | Phase 3 | Completed | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 390 | 2021-10-06 | 2026-09-08 |
| Differentiated Thyroid Cancer: is There a Need for Radioiodine Ablation in Low Risk Patients? rhTSH stimulation, I131, Follow up - Low Risk Differentiated Thyroid Cancer | Phase 3 | Active not recruiting | Gustave Roussy, Cancer Campus, Grand Paris | 776 | 2013-05-13 | 2023-05-17 |
| Minimize Radioactive Iodine Ablation Of Remnant Thyroid in Differentiated Thyroid Cancer I131, I123 - Thyroid Neoplasms | Phase 2 / Phase 3 | Unknown | National Cancer Center, Korea | 556 | 2013-05-01 | 2017-01-20 |
| The Prospective Study of Standard Treatment of Graves Disease Iodine 131 and Prevention of Adverse Reactions Iodine 131 - Hypothyroidism, Exophthalmos | Phase 3 | Unknown | Sun Yat-sen University | 627 | 2007-07-01 | 2015-05-25 |
| Comparison of the Safety and Successful Ablation of Thyroid Remnant in Post-thyroidectomized Euthyroid Patients (i.e. Patients Administered Thyrogen) Versus Hypothyroid Patients (no Thyrogen) Following 131I Administration Thyrogen + Radioiodine (131I) - Thyroid Neoplasms | Phase 3 | Completed | Genzyme, a Sanofi Company | 63 | 2001-12-01 | 2015-03-18 |
| The Dose of Radioactive Iodine Needed to Ablate the Thyroid Remnant Left Behind After Thyroidectomy Radioactive iodine - Thyroid Neoplasms | Phase 3 | Unknown | University of Helsinki | 160 | 2000-01-01 | 2018-03-02 |
| Comparison of Different Doses of 131I in Severe Graves' Hyperthyroidism Radioiodine - Graves Disease | Phase 3 | Completed | Hospital de Clinicas de Porto Alegre | 30 | 1997-02-01 | 2012-09-06 |
Thyroid Neoplasms (4) · Hyperthyroidism (2) · Exophthalmos (1) · Graves Disease (1) · Graves Ophthalmopathy (1) · Hypothyroidism (1) · Thyroid Nodule (1)
Genzyme, a Sanofi Company (1) · Gustave Roussy, Cancer Campus, Grand Paris (1) · Hospital de Clinicas de Porto Alegre (1) · Medical University of Bialystok (1) · National Cancer Center, Korea (1) · Rijnstate Hospital (1) · Sun Yat-sen University (1) · Suzhou Zelgen Biopharmaceuticals Co.,Ltd (1) · University of Helsinki (1) · University of Pisa (1)
China (2) · Brazil (1) · Finland (1) · France (1) · Italy (1) · Netherlands (1) · Poland (1) · South Korea (1)
Agnieszka Adamska, Assoc.Prof. (1) · Ana L Maia, MD, PhD (1) · Eun Kyung Lee, M.D.,Ph.D. (1) · Yansong Lin, PhD (1)